Shaul Kadosh

1.5k total citations
11 papers, 430 citations indexed

About

Shaul Kadosh is a scholar working on Pathology and Forensic Medicine, Epidemiology and Neurology. According to data from OpenAlex, Shaul Kadosh has authored 11 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 4 papers in Epidemiology and 3 papers in Neurology. Recurrent topics in Shaul Kadosh's work include Multiple Sclerosis Research Studies (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Shaul Kadosh is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Shaul Kadosh collaborates with scholars based in United States, Israel and Austria. Shaul Kadosh's co-authors include David Ladkani, Jerry S. Wolinsky, Corey C. Ford, Patricia K. Coyle, Ponnada A. Narayana, Aaron Miller, Kenneth P. Johnson, Paul O’Connor, Massimo Filippi and Giancarlo Comi and has published in prestigious journals such as Blood, Hepatology and Neurology.

In The Last Decade

Shaul Kadosh

10 papers receiving 412 citations

Peers

Countries citing papers authored by Shaul Kadosh

Since Specialization

Citations

This map shows the geographic impact of Shaul Kadosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaul Kadosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaul Kadosh more than expected).

Fields of papers citing papers by Shaul Kadosh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaul Kadosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaul Kadosh. The network helps show where Shaul Kadosh may publish in the future.

Co-authorship network of co-authors of Shaul Kadosh

This figure shows the co-authorship network connecting the top 25 collaborators of Shaul Kadosh. A scholar is included among the top collaborators of Shaul Kadosh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaul Kadosh. Shaul Kadosh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Aramchol improves hepatic fibrosis in metabolic dysfunction–associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology 2024 ·Hepatology ·Vlad Ratziu, Yusuf Yılmaz, (unknown), Scott L. Friedman, C. Lackner, Cynthia Behling, Oscar W. Cummings, (unknown), (unknown), Yossi Gilgun‐Sherki, Tali Gorfine, Shaul Kadosh, Eli Eyal, Arun J. Sanyal	11
2	Use of Combination Premedication Prior to Motixafortide Administration Reduced Severity and Frequency of AEs in the Phase 3 Genesis Trial - a Single Center Analysis 2023 ·Blood ·Zachary Crees, Keith Stockerl‐Goldstein, Mark A. Schroeder, Ravi Vij, Ella Sorani, (unknown), (unknown), (unknown), Shaul Kadosh, John F. DiPersio	0
3	Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study 2022 ·Multiple Sclerosis Journal ·Corey C. Ford, Jeffrey A. Cohen, Andrew Goodman, John Lindsey, Robert P. Lisak, Christopher Luzzio, Amy A. Pruitt, John Rose, Horea Rus, Jerry S. Wolinsky, Shaul Kadosh, (unknown), (unknown), Jessica K. Alexander	2
4	Multimodality assessment of hepatic fibrosis: ranked paired reading and artificial intelligence identifies fibrosis improvement with aramchol missed by conventional staging 2022 ·Journal of Hepatology ·Vlad Ratziu, Yusuf Yılmaz, (unknown), Scott L. Friedman, Carolin Lackner, Cynthia Behling, Oscar W. Cummings, (unknown), (unknown), Yossi Gilgun‐Sherki, Shaul Kadosh, Arun J. Sanyal	1
5	Immunophenotypic and Single-Cell Transcriptional Profiling of CD34+ Hematopoietic Stem and Progenitor Cells Mobilized with Motixafortide (BL-8040) and G-CSF Versus Plerixafor and G-CSF Versus Placebo and G-CSF: A Correlative Study of the Genesis Trial 2021 ·Blood ·Zachary Crees, (unknown), Reyka G. Jayasinghe, Keith Stockerl‐Goldstein, (unknown), Ella Sorani, Debby Ickowicz, (unknown), Shaul Kadosh, John F. DiPersio	1
6	Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study 2021 ·Multiple Sclerosis Journal - Experimental Translational and Clinical ·Peter Rieckmann, Robert Zivadinov, (unknown), Krzysztof Selmaj, Jessica K. Alexander, Shaul Kadosh, (unknown), (unknown), (unknown), (unknown), Mat D. Davis, Omar Khan	5
7	A Multi-Center Phase IIA Trial to Assess the Safety and Efficacy of BL-8040 (a CXCR4 Inhibitor) in Combination with Pembrolizumab and Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma (PDAC) 2019 ·Annals of Oncology ·Manuel Hidalgo, Valerya Semenisty, Bruno Bockorny, Erkut Borazanci, Daniel D. Von Hoff, Jaime Feliú, (unknown), David Gutiérrez Abad, Amnon Peled, Osnat Bohana‐Kashtan, Yosi Gozlan, Ella Sorani, Marya Chaney, Shaul Kadosh, (unknown), Teresa Macarulla	12
8	A randomized trial of a low‐dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease 2017 ·Movement Disorders ·C. Warren Olanow, Karl Kieburtz, Mika Leinonen, Lawrence Elmer, Nir Giladi, Robert A. Hauser, (unknown), (unknown), Mark Lew, David Russell, Shaul Kadosh, (unknown), (unknown), (unknown), (unknown)	26
9	Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial 2007 ·Annals of Neurology ·Jerry S. Wolinsky, Ponnada A. Narayana, Paul O’Connor, Patricia K. Coyle, Corey C. Ford, Kenneth P. Johnson, Aaron Miller, (unknown), Shaul Kadosh, David Ladkani, (unknown)	297
10	Copaxone’s effect on MRI-monitored disease in relapsing MS is reproducible and sustained 2002 ·Neurology ·J. S. Wolinsky, Giancarlo Comi, Massimo Filippi, David Ladkani, Shaul Kadosh, Galia Shifroni, (unknown)	40
11	Alfacalcidol (Alpha D3) and Calcium in Osteoporosis 1994 ·Clinical Orthopaedics and Related Research ·J. Menczel, J. Földes, R. Steinberg, Isaac Leichter, (unknown), Tali Bdolah‐Abram, Shaul Kadosh, (unknown), David Ladkani	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact